Full Text View
Tabular View
Study Results
Related Studies
Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome
This study has been completed.
Study NCT00114127   Information provided by Massachusetts General Hospital

First Received on June 13, 2005.   Last Updated on May 3, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anxiety Disorder
Additional conditions recognized in this trial
Anxiety Disorders
Phobic Disorders
More general conditions related to this trial
Mental Disorders
Interventions listed in this trial
Duloxetine
Placebo
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Uptake Inhibitors
Antidepressive Agents
Central Nervous System Agents
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Massachusetts General Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services